Last10K.com

Plx Pharma Inc. (PLXP) SEC Filing 8-K Material Event for the period ending Tuesday, February 7, 2023

Plx Pharma Inc.

HISTORY TOOLS
CIK: 1497504 Ticker: PLXP

View differences made from one to another to evaluate Plx Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Plx Pharma Inc..

Continue

Assess how Plx Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Plx Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: PLXP
CIK: 1497504
Form Type: 8-K Corporate News
Accession Number: 0001193805-23-000207
Submitted to the SEC: Mon Feb 13 2023 5:16:08 PM EST
Accepted by the SEC: Mon Feb 13 2023
Period: Tuesday, February 7, 2023
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Listing Status

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/plxp/0001193805-23-000207.htm